- Home
- CERS vs NVX Comparison
CERS vs NVX Comparison
Compare CERS & NVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CERS | NVX |
|---|---|---|
| Founded | 1991 | 2012 |
| Country | United States | Australia |
| Employees | N/A | N/A |
| Industry | EDP Services | Industrial Machinery/Components |
| Sector | Technology | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 276.0M | 235.2M |
| IPO Year | 1997 | N/A |
Fundamental Metrics
Financial Performance| Metric | CERS | NVX |
|---|---|---|
| Price | $2.49 | $1.13 |
| Analyst Decision | Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $4.00 | N/A |
| AVG Volume (30 Days) | 1.6M | ★ 1.7M |
| Earning Date | 02-19-2026 | 01-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $199,191,000.00 | $5,931,433.00 |
| Revenue This Year | $25.31 | $165.90 |
| Revenue Next Year | $9.50 | $1,344.85 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 13.03 | N/A |
| 52 Week Low | $1.12 | $0.81 |
| 52 Week High | $2.96 | $3.86 |
Technical Indicators
Market Signals| Indicator | CERS | NVX |
|---|---|---|
| Relative Strength Index (RSI) | 58.68 | 45.57 |
| Support Level | $2.44 | $1.02 |
| Resistance Level | $2.74 | $1.19 |
| Average True Range (ATR) | 0.16 | 0.09 |
| MACD | -0.00 | -0.03 |
| Stochastic Oscillator | 51.76 | 20.00 |
Price Performance
Historical ComparisonAbout CERS Cerus Corporation
Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.
About NVX NOVONIX Limited American Depository Shares
NOVONIX Ltd operates in the lithium-ion battery industry. The company has three operating segments namely Graphite Exploration, Battery Technology, and Battery Materials. Graphite Exploration segment is engaged in the exploration and development of high-grade flake graphite deposits. The Battery Technology segment develops battery cell testing equipment and carries out research and development in battery development. The Battery Materials segment develops and manufactures battery anode materials. The Battery Technology segment generates maximum revenue for the company.